Gates Iragi Mulume

Gates Iragi Mulume

Auto-generated profile, based on publicly available information

Gates Iragi Mulume

Faculty of Medicine, Catholic University of Bukavu, Bukavu, Democratic Republic of the Congo

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2026 in Neurodegenerative Diseases
Verified
Journal Article
Open access
TTTshibambe N. Tshimbombu
Tshibambe N. Tshimbombu
KTKyle E. Thurmann
Kyle E. Thurmann
BDBoris Decourt
Boris Decourt
ANArsene Daniel Nyalundja
Arsene Daniel Nyalundja
SSSamira Braimah Shardow
Samira Braimah Shardow
MSMarwan N. Sabbagh
Marwan N. Sabbagh
Background: Alzheimer’s disease (AD) is an incurable progressive neurodegenerative disorder characterized by the pathological accumulation of amyloid beta (Aβ) plaques and neurofibrillary tangles in the brain. Recent findings have identified dysregulation of autophagy, a cellular mechanism for degradation and recycling, as a crucial contributor to the pathogenesis of AD. This narrative review examines the role of autophagy in the metabolism of Aβ and tau and evaluates current therapeutic strategies aimed at modulating autophagic pathways. Summary: Autophagy is governed by the key molecular regulators mammalian target of rapamycin, adenosine monophosphate-activated protein kinase, Beclin-1, and transcription factor EB, which collectively control the clearance of protein recycling, including aggregates, inside cells. Pharmacological agents such as rapamycin, resveratrol, and trehalose, alongside sigma-1 receptor agonists and gene therapy approaches, have demonstrated potential in modulating autophagy in preclinical and clinical studies. Despite these advances, significant challenges persist, namely, neuronal heterogeneity, optimal timing for therapeutic intervention, and the absence of reliable biomarkers to monitor autophagic activity and treatment efficacy. Key Messages: Targeting autophagy offers a promising and potentially safe avenue for slowing AD progression. Future investigations should prioritize the development of selective autophagy modulators and personalized treatment strategies to restore autophagic flux and enhance clinical outcomes in patients with AD.

1 April 2026 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
BCBashizi Cito
Bashizi Cito
KCKabagale Ansima Corneille
Kabagale Ansima Corneille
IGIragi Mulume Gates
Iragi Mulume Gates
KBKashindi Kikombe Bruno
Kashindi Kikombe Bruno
KRKandi Charles Ruhimbasa
Kandi Charles Ruhimbasa
David LUPANDE MwenebituDavid LUPANDE Mwenebitu
David LUPANDE Mwenebitu
Background: Urinary tract infections (UTIs) represent a major public health concern, particularly in low- and middle-income countries, where they are highly prevalent and increasingly associated with antimicrobial resistance. In the Democratic Republic of Congo (DRC), data on the bacteriological profile and antibiotic susceptibility patterns of uropathogens remain scarce. This study aimed to describe the bacteriological profile, antibiotic resistance patterns, and factors associated with multidrug resistance (MDR) among uropathogens at the Hôpital Provincial Général de Référence de Bukavu (HPGRB). Methods: A retrospective descriptive and analytical study was conducted from July 1 to December 31, 2024, in the Microbiology Department of HPGRB. Urine cultures and Kirby–Bauer antibiograms (EUCAST and CLSI 2024 guidelines) from 380 positive samples were analyzed. Bivariate (χ2/Fisher) and multivariate logistic regression were used to identify factors associated with MDR. The production of extended-spectrum β-lactamases (ESBL) was detected and selected by the search for the champagne cork between clavulanic acid and ceftazidime alone or simply resistance to ceftazidime in the absence of the champagne cork. Results: Among 380 patients with positive urine cultures (55% female), children (40.4%) and elderly patients (41.6%) were the most affected. Escherichia coli (62%) and Klebsiella pneumoniae (21%) predominated, showing high resistance to third-generation cephalosporins and quinolones. Presumed ESBL phenotypes were observed in 76.2% of E. coli and 83.3% of K. pneumoniae, with MDR rates of 70% and 82%, respectively. Surgery department admission was the only independent predictor of MDR (adjusted OR 5.43; 95% CI 1.63– 18.09; p = 0.006). Conclusion: UTIs at HPGRB are dominated by Enterobacterales with high MDR and presumed ESBL rates, though last-line antibiotics remain effective. Continuous surveillance, confirmatory ESBL testing, and targeted antibiotic stewardship are urgently needed to preserve therapeutic options.

1 October 2026 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
CMCarine Rebeka Mapendano
Carine Rebeka Mapendano
GMGates Iragi Mulume
Gates Iragi Mulume
JBJulien Migabo Bacirhukenge
Julien Migabo Bacirhukenge
AMArmand Mulume
Armand Mulume
AMAladin Mugisho
Aladin Mugisho
GNGaylord AMANI NGABOYEKA
Gaylord AMANI NGABOYEKA
Background: University students in the Democratic Republic of the Congo face barriers to sexual and reproductive health (SRH) services. This study examined SRH knowledge, service use and associated factors in Bukavu, South Kivu. Methods: A cross-sectional structured questionnaire survey was conducted in January–February 2025 among 430 students. Previous SRH service use was defined by the direct question asking whether the respondent had ever consulted an SRH service. Categorical comparisons used chi-square or exact tests. Multivariable logistic regression estimated adjusted odds ratios (AORs). Results: The mean age was 22.00 ± 3.03 years. Of 430 students, 325 (75.6%) met the study-specific threshold for good SRH knowledge and 175 (40.7%) reported previous service use. In the adjusted model (n = 413), service use was associated with healthcare professionals as an information source (AOR 1.58, 95% CI 1.01– 2.46), reporting cost as a barrier (AOR 1.62, 95% CI 1.05– 2.52), and sexual intercourse in the previous three months (AOR 2.04, 95% CI 1.33– 3.11). Good SRH knowledge was inversely associated with use (AOR 0.50, 95% CI 0.30– 0.82). Conclusion: Reported SRH service use was limited despite a high proportion meeting the study’s knowledge threshold. The associations suggest considering practical access, engagement with healthcare professionals and students’ needs alongside education. They do not establish causal effects.

1 July 2026 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
CACorneille Kabagale Ansima
Corneille Kabagale Ansima
GMGates Iragi Mulume
Gates Iragi Mulume
BMBenjamin Jibu Maroyi
Benjamin Jibu Maroyi
SMStella Alanga Murhabazi
Stella Alanga Murhabazi
KKKein Kalume Kamwanga
Kein Kalume Kamwanga
David LUPANDE MwenebituDavid LUPANDE Mwenebitu
David LUPANDE Mwenebitu
Background: Antimicrobial resistance (AMR) is a major global public health threat, disproportionately affecting low- and middle-income countries, particularly in sub-Saharan Africa where microbiological surveillance remains limited. Objective: To describe the bacterial ecology, antibiotic resistance profiles, and major resistance phenotypes among clinical isolates collected at the Bukavu Provincial General Referral Hospital in 2024. Methods: A retrospective study was conducted on 1801 non-duplicate bacterial isolates recovered from routine clinical specimens. Bacterial identification was performed using conventional microbiological methods, and antimicrobial susceptibility testing was interpreted according to EUCAST 2024 recommendations. Resistance profiles were analyzed by bacterial group, antibiotic class, and major resistance phenotypes. Results: Enterobacterales predominated (80.4%, n=1448), followed by Gram-positive cocci (11.4%, n=205) and non-fermenting Gram-negative bacilli (7.9%, n=142). Escherichia coli was the most frequently isolated species (37.2%, n=670). High resistance rates were observed for amoxicillin-clavulanic acid (95.6%), ampicillin (86.0%), ceftazidime (82.0%), and ceftriaxone (62.0%). Carbapenem resistance remained comparatively lower, with resistance rates of 14.4% for imipenem and 13.1% for meropenem. Among Enterobacterales tested for at least one third-generation cephalosporin, 80.0% (986/1,233) showed an ESBL-compatible phenotype. Multidrug resistance was observed in more than 70% of isolates. Conclusion: This study demonstrates a high burden of antimicrobial resistance in a tertiary hospital in eastern Democratic Republic of Congo, characterized by widespread resistance to commonly used antibiotics and a high frequency of ESBL-compatible Enterobacterales. Strengthening microbiological surveillance, antimicrobial stewardship, and infection prevention strategies is urgently needed in this setting.

14 May 2026 in World Neurosurgery
Verified
Journal Article
Open access
TTTshibambe N. Tshimbombu
Tshibambe N. Tshimbombu
JMJosué Aganze Mwambali
Josué Aganze Mwambali
GIGates Mulume Iragi
Gates Mulume Iragi
KTKyle E. Thurmann
Kyle E. Thurmann
PBPaige Banyas
Paige Banyas
SKSupreet Kaur
Supreet Kaur
Current neuroendovascular devices, primarily fabricated from nitinol, platinum, and cobalt-chromium alloys, exhibit clinical efficacy but also possess inherent material limitations affecting performance, conformability in complex anatomies, long-term biocompatibility, and cost. This study evaluates the potential of alternative mineral resources, specifically niobium, tantalum, and cobalt, as foundational elements for next-generation neurovascular biomaterials, addressing current device limitations and challenges impeding clinical translation. A narrative review was conducted by searching relevant scientific databases (PubMed, Scopus, Web of Science, IEEE Xplore), materials science literature, industry reports, and policy documents. The synthesis focused on neurovascular device materials, global mineral supply chains, and biomedical regulatory pathways, linking material properties to neurointerventional needs. Niobium, tantalum, and cobalt offer targeted solutions for neurovascular innovation. Tantalum's superior radiopacity addresses poor visibility of current stents. Niobium alloys offer potential for tailored superelasticity, promising more compliant devices. Advanced cobalt-chromium alloys enable stronger, thinner-strutted devices, facilitating miniaturization. Although these minerals are available globally, establishing reliable, medical-grade processing infrastructure and ensuring ethical sourcing remains critical for widespread biomedical application. The use of niobium, tantalum, and refined cobalt represents a technically grounded pathway for advancing neurovascular care. Realizing this potential requires leveraging technologically advanced global value chains and international collaboration to drive innovation that is technologically superior and ethically sound.